[Anticonvulsive effect of 2-amino-5-(5,5-diphenyl-3-hydantoyl)-valeric acid after intravenous administration in animal experiments].
D061605:Administration, Intravenous; D032761:Animal Experimentation; D000818:Animals; D001713:Biphenyl Compounds; D006827:Hydantoins / Q000494:pharmacology*; D010421:Pentanoic Acids; D012640:Seizures
D001713:Biphenyl Compounds; D006827:Hydantoins; D010421:Pentanoic Acids; C010574:biphenyl; C038780:n-pentanoic acid
CONVULSIONS/experimental; HYDANTOINS/effects
Die krampfhemmende Wirkung der alpha-Amino-delta-diphenylhydantoylvaleriansäure bei intravenöser Verabreichung im Tierversuch.